Article Details
Retrieved on: 2023-01-05 17:00:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its ...
Article found on: investchronicle.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here